Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland.

To assess the impact of international consensus conference guidelines on the attitude of Swiss specialists when facing the decision to treat chronic hepatitis C patients. Questionnaires focusing on the personal situation and treatment decisions were mailed to 165 patients who were newly diagnosed with hepatitis C virus (HCV) infection and enrolled into the Swiss Hepatitis C Cohort Study during the years 2002-2004. Survey respondents (n = 86, 52.1%) were comparable to non-respondents with respect to severity of liver disease, history of substance abuse and psychiatric co-morbidities. Seventy percent of survey respondents reported having been offered antiviral treatment. Patients deferred from treatment had less advanced liver fibrosis, were more frequently infected with HCV genotypes 1 or 4 and presented more often with a history of depression. There were no differences regarding age, socio-economic background, alcohol abuse, intravenous drug abuse or methadone treatment when compared with patients to whom treatment was proposed. Ninety percent of eligible patients agreed to undergo treatment. Overall, 54.6% of respondents and 78.3% of those considered eligible had actually received antiviral therapy by 2007. Ninety-five percent of patients reported high satisfaction with their own hepatitis C management. Consistent with latest international consensus guidelines, patients enrolled in the Swiss Hepatitis C Cohort with a history of substance abuse were not withheld antiviral treatment. A multidisciplinary approach is warranted to provide antiviral treatment to patients suffering from depression.

Liver kidney microsomes type 1 antibodies are associated with 80% reduction of the CYP2D6 activity in patients with chronic hepatitis C

Introduction Liver kidney microsomal type 1 (LKM-1) antibodies have been shown to decrease CYP2D6 activity in vitro. We investigated whether LKM-1 antibodies might reduce CYP2D6 activity also in vivo.Materials and Methods All patients with chronic hepatitis C and LKM-1 antibodies enrolled in the Swiss Hepatitis C Cohort Study (SCCS) were assessed: ten were eligible and fi tted to patients without LKM-1 antibodies. Patients were genotyped for CYP2D6 variants to exclude individuals with a poor metabolizer genotype. CYP2D6 activity was measured by a specifi c substrate using the dextromethorphan/dextrorphan (DEM/DOR) metabolic ratio to classify patients into four activity phenotypes (i.e. ultrarapid, extensive, intermediate and poor metabolizers). The concordance between phenotype based on DEM/DOR ratio and phenotype expected from genotype was examined in LKM-1 positive and negative patients. Groups were compared with respect to the DEM/DOR metabolic ratio.Results All patients had a CYP2D6 extensive metabolizer genotype. The observed phenotype was concordant with CYP2D6 genotype in most LKM-negative patients, whereas only three (30%) LKM-1 positive patients had a concordant phenotype (six presented an intermediate and one a poor metabolizer phenotype). The median DEM/DOR ratio was six-fold higher in LKM-1 positive than in LKM-1 negative patients (0.096 vs. 0.016, p = 0.004), indicating that CYP2D6 metabolic function was significantly reduced in the presence of LKM-1 antibodies.Conclusion In chronic hepatitis C patients with LKM-1 antibodies, the CYP2D6 metabolic activity was on average reduced by 80%. The impact of LKM-1 antibodies on CYP2D6-mediated drug metabolism pathways warrants further translational studies in the setting of new protease inhibitor therapies

Kyste synovial de l'épaule traité par aspiration et infiltration sous échographie : rapport de 3 cas avec pathologies différentes

Introduction: Les kystes synoviaux localisés à l'épaule sont des conditions rares résultant de tendinopathies rompues de la coiffe des rotateurs, d'une omarthrose sévère, d'arthropathies microcristallines de l'articulation acromio-claviculaire ou gléno-humérale, ou d'une atteinte secondaire à un rhumatisme inflammatoire chronique. Ils se présentent cliniquement le plus souvent sous la forme d'une tuméfaction fluctuante indolore en regard du moignon de l'épaule ou de l'articulation acromio-claviculaire. L'imagerie par échographie permet de caractériser aisément la présence de ces kystes. La prise en charge thérapeutique est généralement non invasive par aspiration-infiltration. Les cas réfractaires sont susceptibles de subir une intervention chirurgicale en fonction de l'âge et de l'état général du patient.Patients et Méthodes: Nous rapportons les cas de 3 patients avec imagerie par échographie et IRM ou Scanner. Le premier cas est celui d'un homme de 47 ans, greffé rénal, présentant une arthrite récidivante des épaules sur arthropathie microcristalline mixte. De multiples kystes synoviaux sont mis en évidence dans la musculature du supra-épineux gauche, communiquant avec l'articulation acromio-claviculaire. Le patient a bénéficié à plusieurs ponctions-infiltrations dirigées par ultrasonographie. Le deuxième cas est celui d'un patient de 32 ans connu pour une arthrite psoriasique évoluant depuis 6 ans. Il présente une importante tuméfaction en regard du biceps à gauche sur un kyste synovial provenant de l'articulation gléno-humérale. Il bénéficie également d'une ponction-infiltration dirigée par ultrason. Le troisième cas est celui d'une femme de 91 ans chez qui au status d'entrée on objective une volumineuse masse polylobée en regard de l'acromio-claviculaire, présente depuis 2002 qui n'a jamais été symptomatique. Un US, puis un CT montrent qu'il s'agit de volumineux kystes articulaires en relation avec une arthropathie sévère dégénérative et à apatite de l'acromio-claviculaire.Résultats: Les trois patients ont bénéficié d'une imagerie diagnostique par échographie complétée par une IRM ou Scanner. Tous les trois ont également subi une aspiration dirigée sous échographie. Dans le premier cas, deux aspiration-infiltration des kystes qui apportaient une évolution favorable avec diminution important des kystes. Dans le deuxième cas nous avons retrouvé un kyste après 2 aspirations et dans ce cas une intervention chirurgicale est considérée. Dans le troisième cas, asymptomatique, une résection à visée esthétique a été refusée par la patiente.Conclusion: Les kystes synoviaux localisés à l'épaule restent des conditions rares, provenant d'entités diverses. Nous rapportons le développement de kystes synoviaux de l'épaule dans une arthropathie microcristalline chez un patient greffé rénal, dans une arthrite psoriasique chez un jeune patient en poussée inflammatoire, et finalement de gros kystes asymptomatiques chroniques sur une atteinte dégénérative et microcristalline chez une patiente âgée. Le diagnostic de ces kystes peut être rapidement obtenu par échographie, permettant l'aspiration guidée avec analyse du liquide. En raison d'un fort taux de récidive malgré un traitement par aspiration-infiltration, une intervention chirurgicale de ces kystes est considérée.

L'analyse de la moelle osseuse en pratique clinique : intérêt de l'examen combiné, aspiration et biopsie

L'examen combinant aspiration (cytologie) et biopsie (histologie) permet d'obtenir un maximum d'informations sur la moelle hématopoïétique. Les indications à l'examen combiné sont les lymphomes, le myélome multiple et autres gammapathies, les syndromes myéloprolifératifs et myélodysplasiques, les leucémies aiguës, la recherche de métastases, de processus infectieux (granulomes) et les cytopénies Inexpliquées. Le matériel d'aspiration permet un examen cytologique fin, la cytométrie de flux, la cytogénétique, les cultures cellulaires et les analyses microbiologiques. La biopsie, indispensable lorsque l'aspiration est infructueuse (« sèche »), offre la possibilité d'examiner un plus grand volume de tissu, dont l'architecture est conservée, d'apprécier la cellularité, de détecter des lésions compactes ou fibreuses et d'appliquer l'immunohistochimie.

Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir.

Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. Two first-generation protease inhibitors, telaprevir and boceprevir, have recently been approved for the treatment of chronic hepatitis C genotype 1. Triple therapy comprising pegylated interferon-α, ribavirin and telaprevir or boceprevir increases sustained virological response rates to ~70% and allows to shorten treatment duration in ~½ of treatment-naïve patients with chronic hepatitis C genotype 1. Sustained virological response rates in treatment-experienced patients depend on the response to previous treatment, ranging from >80% in previous relapsers to ~30% in previous null responders. These advances come at the expense of new adverse effects and increased cost. In addition, treatment of chronic hepatitis C will become more complex. In these times of changing medical practice, the present expert opinion statement by the Swiss Association for the Study of the Liver shall provide guidance on the treatment of chronic hepatitis C with triple therapy comprising telaprevir or boceprevir.

The adolescent with a chronic condition. Part II: healthcare provision.

The treatment and management of chronic conditions during adolescence pose specific issues that need to be appropriately handled by health professionals. In this paper, questions related to disclosure of the diagnosis, the management of adherence to therapy, the need for an interdisciplinary network approach, lifestyles' anticipatory guidance and prevention, and the transition into an adult healthcare setting are reviewed. Special areas such as the issue of life threatening diseases and the ethical aspects of the treatment of chronic conditions are also discussed.

Dysfonction métabolique et stress chronique: un nouveau regard sur la pandémie de "diabésité" [Metabolic dysfunction and chronic stress: a new sight at "diabesity" pandemic]

Chronic stress in Western society can activate the autonomus, neuroendocrine and inflammatory/immunlogic systems. Chronic exposure to stressors can indeed stimulate the hypothalamic-pituitary-adrenal axis and induce a disbalance between anabolic and catabolic hormones, responsible of an increased in visceral fat and of insulin resistance. These metabolic consequences can lead to pre-diabetes. Exposure to chronic stress results in allostatic load and its pathophysiologic consequences. The knowledge of this mecanisms and the cardiovascular and metabolic risk related, should influence our way of thinking about patient care. To decrease allostatic load, practitioners can rely on therapeutic relation. Therapeutic education is one of the skill that can be use to create therapeutic relation.

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase and a nuclease that restricts HIV-1 in noncycling cells. Germ-line mutations in SAMHD1 have been described in patients with Aicardi-Goutières syndrome (AGS), a congenital autoimmune disease. In a previous longitudinal whole genome sequencing study of chronic lymphocytic leukemia (CLL), we revealed a SAMHD1 mutation as a potential founding event. Here, we describe an AGS patient carrying a pathogenic germ-line SAMHD1 mutation who developed CLL at 24 years of age. Using clinical trial samples, we show that acquired SAMHD1 mutations are associated with high variant allele frequency and reduced SAMHD1 expression and occur in 11% of relapsed/refractory CLL patients. We provide evidence that SAMHD1 regulates cell proliferation and survival and engages in specific protein interactions in response to DNA damage. We propose that SAMHD1 may have a function in DNA repair and that the presence of SAMHD1 mutations in CLL promotes leukemia development.

Improvement of chronic congestive heart-failure by oral captopril

Catopril, an inhibitor of angiotensin converting enzyme, was given orally during cardiac catheterisation to 6 normotensive patients with refractory congestive heart-failure. 60--180 minutes after administration of 25 mg captopril, arterial pressure fell by 25%, cardiac index rose by 38%, and left-ventricular pressure and right-atrial pressure fell by 25% and 40% respectively. Plasma-renin activity rose while plasma noradrenaline and aldosterone fell. These data suggest that, in the short term, captopril can reduce both preload and afterload, and improve cardiac function, in refractory congestive heart-failure.

Chronic bradykinin receptor blockade modulates neonatal renal function.

Recent data indicate that bradykinin participates in the regulation of neonatal glomerular function and also acts as a growth regulator during renal development. The aim of the present study was to investigate the involvement of bradykinin in the maturation of renal function. Bradykinin beta2-receptors of newborn rabbits were inhibited for 4 days by Hoe 140. The animals were treated with 300 microg/kg s.c. Hoe 140 (group Hoe, n = 8) or 0.9% NaCl (group control, n = 8) twice daily. Clearance studies were performed in anesthetized rabbits at the age of 8-9 days. Bradykinin receptor blockade did not impair kidney growth, as demonstrated by similar kidney weights in the two groups, nor did it influence blood pressure. Renal blood flow was higher, while renal vascular resistance and filtration fraction were lower in Hoe 140-treated rabbits. No difference in glomerular filtration rate was observed. The unexpectedly higher renal perfusion observed in group Hoe cannot be explained by the blockade of the known vasodilator and trophic effect of bradykinin. Our results indicate that in intact kallikrein-kinin system is necessary for the normal functional development of the kidney.